Lantheus Holdings, Inc. 13D and 13G filings for PROGENICS PHARMACEUTICALS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-06-23 10:26 am Sale | 2020-06-19 | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Lantheus Holdings Inc. LNTH | 1,000 100.000% | -8,010,733 (-99.99%) | Filing |
| 2020-04-23 5:00 pm Purchase | 2020-04-14 | 13D | PROGENICS PHARMACEUTICALS INC PGNX | Lantheus Holdings Inc. LNTH | 8,011,733 9.300% | 8,011,733 (New Position) | Filing |